Detalles de la búsqueda
1.
Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors.
Dig Dis
; 41(3): 422-430, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257291
2.
Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
BMC Cancer
; 22(1): 737, 2022 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794525
3.
Breakfast consumption frequency is associated with dyslipidemia: a retrospective cohort study of a working population.
Lipids Health Dis
; 21(1): 33, 2022 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35351127
4.
Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study.
Discov Oncol
; 14(1): 105, 2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336826
5.
Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors.
Cancer Med
; 11(24): 4880-4888, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35599583
6.
Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors.
Ann Palliat Med
; 10(11): 11244-11254, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34670386
7.
Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
Int J Pharm
; 447(1-2): 171-81, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23500766
8.
The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo.
J Ethnopharmacol
; 139(3): 721-7, 2012 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22143155
Resultados
1 -
8
de 8
1
Próxima >
>>